EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
Citation
Fanti , S , Brigantii , A , Emmett , L , Fizazi , K , Gillessen , S , Goffin , K , Hadaschik , B A , Herrmann , K , Kunikowska , J , Maurer , T , MacLennan , S , Mottet , N , Murphy , D G , Oprea-Lager , D E , O’Sullivan , J M , Oyen , W JG , Rouvière , O , Sartor , O , Stenzl , A , Van Poppel , H , Walz , J , Witjes , W & Bjartell , A 2022 , ' EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy ' , European Urology Oncology , vol. 5 , no. 5 , pp. 530-536 . https://doi.org/10.1016/j.euo.2022.05.003
Rights
©2022. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).